Table 3

 Symptom limited peak of constant load cycle exercise at 75% Wmax (57 (6) W, 39 (2)% of predicted maximum)

VariableRA + PLRA + BDO2 + PLO2 + BDp value (ANOVA)
Values are mean (SE).
*p<0.05 v RA+PL; †p<0.05 v RA+BD; ‡p<0.05 v O2+PL.
RA, room air; BD, bronchodilator; PL, placebo; O2, oxygen; V̇co2, carbon dioxide output; V̇e, minute ventilation; F, breathing frequency; Ti, Te, inspiratory and expiratory time; Vt, total volume; IC, inspiratory capacity; Sao2, arterial saturation; IRV, inspiratory reserve volume; EELV, end expiratory lung volume; EILV, end inspiratory lung volume; TLC, total lung capacity; Paco2, arterial carbon dioxide tension; HCO3, bicarbonate.
Endurance time (min)5.4 (0.9)7.1 (1.3)8.5 (1.4)*10.4 (1.6)*†‡0.002
Dyspnoea (Borg)6.4 (0.5)5.8 (0.6)5.4 (0.6)5.3 (0.5)0.095
Leg discomfort (Borg)4.9 (0.5)5.4 (0.5)5.2 (0.5)5.9 (0.5)0.069
Heart rate (beats/min)122 (5)124 (4)121 (5)124 (5)0.239
Sao2 (%)92 (1)93 (1)97 (0)*†97 (1)*†<0.0005
co2 (l/min)1.15 (0.11)1.26 (0.12)*1.21 (0.12)1.30 (0.14)*0.071
e (l/min)38.6 (2.9)44.3 (3.5)*37.2 (2.7)†41.5 (3.5)*†‡<0.0005
e/V̇co235.5 (1.6)36.9 (1.6)*32.4 (1.3)*†33.5 (1.5)†<0.0005
F (breaths/min)34 (2)36 (2)33 (2)34 (2)0.063
Te (s)1.08 (0.05)1.06 (0.06)1.12 (0.06)1.10 (0.06)0.202
Ti (s)0.73 (0.04)0.71 (0.04)0.75 (0.04)0.74 (0.05)0.526
Vt (l)1.16 (0.09)1.28 (0.10)*1.14 (0.08)†1.26 (0.10)*‡<0.0005
IC (l)1.50 (0.12)1.67 (0.13)*1.48 (0.10)†1.68 (0.13)*‡<0.0005
IRV (l)0.34 (0.05)0.37 (0.06)0.34 (0.04)0.42 (0.05)0.335
EELV (l)5.17 (0.22)4.91 (0.24)*5.30 (0.23)†4.90 (0.21)*‡<0.0005
EILV/TLC (%)95 (1)94 (1)95 (1)94 (1)0.227
Paco2 (mm Hg)41.4 (1.2)40.2 (1.7)45.7 (1.4)*†43.5 (2.0)*‡0.012
HCO3 (mmol/l)22.5 (0.5)22.0 (0.5)23.5 (0.7)*†22.6 (0.5)0.028
Base excess (mmol/l)−2.4 (0.5)−2.7 (0.5)−2.3 (0.8)−2.8 (0.5)0.342
pH7.36 (0.01)7.36 (0.01)7.33 (0.01)7.34 (0.01)0.713